Navigation Links
Medco Tops Fortune's Lists of 'World's Most Admired' Companies for Third Consecutive Year
Date:3/8/2010

FRANKLIN LAKES, N.J., March 8 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS), captured the No. 1 position within the Health Care: Pharmacy and Other Services sector on Fortune's World's Most Admired Companies List for the third consecutive year.  Medco ranked highest in five categories within that sector: innovation, use of corporate assets, quality of management, financial soundness, and quality of products/services.

According to the Fortune survey, Medco also received the following additional honors: No. 2 in the "Health Care: Pharmacy and Other Services" category for people management, long term investment and global competitiveness; and among the most admired companies in New Jersey.

Fortune, in partnership with the Hay Group, surveyed more than 667 companies across 55 industry sectors worldwide. To establish the rankings, executives, directors, and securities analysts were asked to rate companies in their own industry on nine criteria, from investment value to social responsibility. Results are featured in the March 22 issue of Fortune magazine.

"We are honored to be ranked the highest of our industry peers," said Medco Chairman and CEO David B. Snow, Jr. "That ranking validates our commitment to leveraging the power of advanced pharmacy to provide clinical excellence for our members and drive down total healthcare costs for our valued clients."

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for approximately 65 million members.

With more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2009 revenue of nearly $60 billion, Medco ranks 45th on the Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies.

For more information, go to http://www.medcohealth.com.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.

SOURCE Medco Health Solutions, Inc.

Back to top

RELATED LINKS
http://www.medcohealth.com

'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Medco Acquires Leading Genetics Healthcare Company, DNA Direct
2. Great Customer Service Just Got Better as Emedco Announces the Launch of their Completely Updated and Enhanced Website
3. N2Care Unveils Backyard Smart MEDcottage
4. Medco Health Solutions, United Drug Announce U.K. Homecare Pharmacy Joint Venture Serving Patients with Chronic and Complex Health Conditions; Innovations to Improve Clinical Quality, Reduce Costs
5. Gold Standard/Elsevier Launches MedCounselor Consumer Drug Information Modules
6. Medco Announces Date for Second-Quarter 2009 Financial Results
7. PATHFAST(R) Rapid Whole Blood Immunoassay Analyzer from Polymedco
8. Medcos Advanced Pharmacy Adds 162 New Jobs for Total of 1,400
9. Medco to Present at June 2009 Investor Conferences
10. Medco CEO to Present at the Sanford C. Bernstein & Co. LLC 25th Annual Strategic Decision Conference 2009
11. Medco to Present at the Deutsche Bank 34th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The physicians of KSF Orthopaedic Center ... Houston Area. The new location is located at 2255 E. Mossy Oaks Rd., Suite ... This newest location will provide patients living in the north Houston area (The Woodlands, ...
(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy ... 960 Gruene Road in Building 2. The clinic is the group’s second in New ... says opening the company’s second New Braunfels location brings things full circle for the ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The IoT ... and WiFi connectivity are making a huge impact on businesses and individual consumers alike. ... estimates the IoT will have a value anywhere from $4 trillion to $11 trillion ...
(Date:3/23/2017)... ... ... of adults are unaware of the dangers that infectious bacteria play in mouth disease, while ... a day that dentists recommend. The ramifications of improper oral upkeep go far beyond bad ... 164 million hours of work each year due to dental issues. That is why Mediaplanet ...
(Date:3/23/2017)... ... ... March is National Kidney Month – the perfect time to pause and ... health. Every day, two kidneys filter about 120 to 150 quarts of blood. Put ... waste, regulating fluid levels and blood pressure, supporting bone health and promoting red blood ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Research and Markets has announced the ... Strategies" report to their offering. ... Pain Management in the ... their physical pain, emphasizing consumer survey analysis, including trends over ... adults who have selected illnesses/conditions strongly associated with physical pain ...
(Date:3/24/2017)... 24, 2017 ShangPharma, a leading ... cost-effective drug development and discovery services, technology, ... industry, announced today the intent for a ... be consolidating the Contract Research Organizations (CRO) ... ChemPartner. These entities include ChemPartner Shanghai, ChemPartner ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with a ... Merck & Co., Inc., Biogen and Sanofi are involved in the development ... of which one is in Phase III stage, 15 are in Phase ...
Breaking Medicine Technology: